AI-generated summary
The authors reviewed published studies of photobiomodulation as a possible adjunct for lung inflammation relevant to COVID-19. Seventeen papers, all in animal models, were included, and the authors report that photobiomodulation reduced pulmonary edema, neutrophil influx and several pro-inflammatory markers. The authors note that all evidence came from animal studies, so the findings do not establish effects in people.
- Studies included
- 17
- Who or what was studied
- Animal models of acute lung inflammation or acute respiratory distress syndrome; no human participants were included.
- Limits stated in the abstract
- All 17 included studies were in animal models, so no human evidence was reviewed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Inflammation, Reactive oxygen species, Nitric oxide, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.